Imura Y - Search Results

1

Synergistic antithrombotic properties of G4120, a RGD-containing synthetic peptide, and argatroban, a synthetic thrombin inhibitor, in a hamster femoral vein platelet-rich thrombosis model.

Imura Y, Stassen JM, Vreys I, Lesaffre E, Gold HK, Collen D. Imura Y, et al. Thromb Haemost. 1992 Sep 7;68(3):336-40. Thromb Haemost. 1992. PMID: 1440501

2

Antithrombotic properties of L-cysteine, N-(mercaptoacetyl)-D-Tyr-Arg-Gly-Asp-sulfoxide (G4120) in a hamster platelet-rich femoral vein thrombosis model.

Imura Y, Stassen JM, Bunting S, Stockmans F, Collen D. Imura Y, et al. Blood. 1992 Sep 1;80(5):1247-53. Blood. 1992. PMID: 1515641 Free article.

3

Comparative antithrombotic effects of heparin, recombinant hirudin and argatroban in a hamster femoral vein platelet-rich mural thrombosis model.

Imura Y, Stassen JM, Collen D. Imura Y, et al. J Pharmacol Exp Ther. 1992 Jun;261(3):895-8. J Pharmacol Exp Ther. 1992. PMID: 1602394

4

Thrombolytic and pharmacokinetic properties of an immunoconjugate of single-chain urokinase-type plasminogen activator (u-PA) and a bispecific monoclonal antibody against fibrin and against u-PA in baboons.

Imura Y, Stassen JM, Kurokawa T, Iwasa S, Lijnen HR, Collen D. Imura Y, et al. Blood. 1992 May 1;79(9):2322-9. Blood. 1992. PMID: 1571545 Free article.

5

Effects of thromboxane A2 synthase inhibitors (CV-4151 and ozagrel), aspirin, and ticlopidine on the thrombosis caused by endothelial cell injury.

Terashita Z, Imura Y, Kawamura M, Kato K, Nishikawa K. Terashita Z, et al. Among authors: imura y. Thromb Res. 1995 Mar 1;77(5):411-21. doi: 10.1016/0049-3848(95)93877-3. Thromb Res. 1995. PMID: 7778056

6

The role of thromboxane (TX) A2 in rabbit arterial thrombosis induced by endothelial damage.

Imura Y, Terashita Z, Nishikawa K. Imura Y, et al. Thromb Res. 1990 Jul 1;59(1):195-205. doi: 10.1016/0049-3848(90)90284-j. Thromb Res. 1990. PMID: 2119075

7

Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model.

Imura Y, Kiyota Y, Nagai Y, Nishikawa K, Terashita Z. Imura Y, et al. Thromb Res. 1995 Jul 1;79(1):95-107. doi: 10.1016/0049-3848(95)00094-8. Thromb Res. 1995. PMID: 7495108

8

Antithrombotic effects of TAK-029, a novel GPIIb/IIIa antagonist, in guinea pigs: comparative studies with ticlopidine, clopidogrel, aspirin, prostaglandin E1 and argatroban.

Kawamura M, Imura Y, Moriya N, Kita S, Fukushi H, Sugihara H, Nishikawa K, Terashita Z. Kawamura M, et al. Among authors: imura y. J Pharmacol Exp Ther. 1996 Apr;277(1):502-10. J Pharmacol Exp Ther. 1996. PMID: 8613960

9

TCV-116, a novel angiotensin II receptor antagonist, prevents intimal thickening and impairment of vascular function after carotid injury in rats.

Kawamura M, Terashita Z, Okuda H, Imura Y, Shino A, Nakao M, Nishikawa K. Kawamura M, et al. Among authors: imura y. J Pharmacol Exp Ther. 1993 Sep;266(3):1664-9. J Pharmacol Exp Ther. 1993. PMID: 8371164

10

Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats.

Shibouta Y, Terashita Z, Imura Y, Shino A, Kawamura M, Ohtsuki K, Ohkawa S, Nishikawa K, Fujiwara Y. Shibouta Y, et al. Among authors: imura y. Kidney Int. 1991 May;39(5):920-9. doi: 10.1038/ki.1991.115. Kidney Int. 1991. PMID: 2067208 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters